Revance Therapeutics Inc (NASDAQ:RVNC) price closed lower on Monday, November 11 and dropping -6.76% below its previous close. A look at the daily price movement shows that the last close reads $3.70, with intraday deals fluctuated between $3.36 and $3.9. The company’s 5Y monthly beta
Revance Therapeutics Inc (NASDAQ:RVNC) at last check was buoying at $3.72 on current market day with a fall of -35.64% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $5.78 with its
Revance Therapeutics Inc (NASDAQ:RVNC) price on Friday, October 25, fall -11.32% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $4.70. A look at the stock’s price movement, the close in the last trading session was $5.30, moving
Revance Therapeutics Inc (NASDAQ:RVNC) at last check was buoying at $5.17 on current market day with a fall of -0.19% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $5.18 and 5Y
Revance Therapeutics Inc (NASDAQ:RVNC) traded at $5.28 at close of the session on current trade day and made an upward move of 0.38% on its previous day’s price. Looking at the stock we see that its previous close was $5.26 and the beta (5Y monthly)
Revance Therapeutics Inc (NASDAQ:RVNC) price on current trading day, rose 1.35% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.26. A look at the stock’s price movement, the close in the last trading session was $5.19, moving
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
